The gamble between oncolytic virus therapy and IFN
Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects. The antiviral effect of IFN itself has a negative impact on the inhibition of oncolytic virus or tumor eradication. Therefore, it is very...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 971674 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
25.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Various studies are being conducted on oncolytic virotherapy which one of the mechanisms is mediating interferon (IFN) production by it exerts antitumor effects. The antiviral effect of IFN itself has a negative impact on the inhibition of oncolytic virus or tumor eradication. Therefore, it is very critical to understand the mechanism of IFN regulation by oncolytic viruses, and to define its mechanism is of great significance for improving the antitumor effect of oncolytic viruses. This review focuses on the regulatory mechanisms of IFNs by various oncolytic viruses and their combination therapies. In addition, the exerting and the producing pathways of IFNs are briefly summarized, and some current issues are put forward. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors have contributed equally to this work This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology Edited by: Jieying Bai, Academy of Military Medical Sciences (AMMS), China Reviewed by: Wenyan Zhang, First Affiliated Hospital of Jilin University, China; Guoli Shi, National Institutes of Health (NIH), United States |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2022.971674 |